Document is current
Any future updates will be listed below
-
Authors
Kronfli, Nadine https://orcid.org/0000-0003-2724-0496
Linthwaite, Blake
Sheehan, Nancy
Cox, Joseph
Hardy, Isabelle
Lebouché, Bertrand
de Pokomandy, Alexandra
Frenette, Charles
Roger, Michel
Klein, Marina B.
- License Information
-
More Information
Article History
Received: 13 August 2019
Accepted: 9 December 2019
First Online: 16 December 2019
Ethics approval and consent to participate
: This study was approved by the Research Institute of the McGill University Health Centre Research Ethics Board (MUHC 2019–5037). Given the retrospective nature of the study, patient consent was not obtained.
: Not applicable. All our data are anonymised. We have removed any specific contextual identifiers and used systematic codes.
: None of the authors feel in conflict of interest with regards to this study and there was no pharmaceutical industry support to conduct this study. Blake Linthwaite, Nancy Sheehan, Isabelle Hardy, Charles Frenette and Michel Roger have no conflicts of interest to declare. Nadine Kronfli has received consulting fees from ViiV Healthcare, Merck and Gilead; research funding from Gilead; and payment for lectures from Gilead. Joseph Cox has received consulting fees from ViiV Healthcare and Gilead; research funding from ViiV Healthcare, Merck and Gilead; and payment for lectures from Gilead. Bertrand Lebouché has received consulting fees from ViiV Healthcare, Merck and Gilead; research funding from Merck, Gilead and Abbvie; and payment for lectures from Merck and Gilead. Alexandra de Pokomandy has received consulting fees from ViiV Healthcare. Marina B. Klein has received consulting fees from ViiV Healthcare, BMS, Merck, Gilead and AbbVie; and research funding from Merck, Gilead and ViiV Healthcare.
